Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
A formulation excipient is a component of a medicine other than its active drug ingredient. Excipients help turn the active ingredient into a usable, stable, and consistent dosage form. They can affect a product's size, texture, appearance, taste, release, preservation, or ease of manufacturing. Although they are commonly called inactive ingredients, some can still affect tolerability, absorption, or product performance.
read more about formulation excipient ...Excipients can add bulk, hold a tablet together, help it break apart, protect a medicine from moisture, or keep ingredients evenly distributed. They can also improve taste, control acidity, prevent microbial growth, or help a poorly soluble drug dissolve. Injectable, inhaled, topical, and oral products require different excipient properties. The selected ingredients must work with the active drug, dosage form, route, packaging, and intended shelf life.
Common categories include fillers, binders, disintegrants, lubricants, coatings, solvents, preservatives, buffers, surfactants, sweeteners, flavors, and coloring agents. Stabilizers can protect proteins or other sensitive drugs from chemical or physical damage. Release-controlling polymers can slow or delay delivery of the active ingredient. One excipient can perform several functions within the same formulation.
Manufacturers evaluate an excipient's identity, purity, amount, function, and compatibility with the active ingredient. Safety is considered in relation to the route, concentration, treatment duration, and patient population. Testing can examine stability, dissolution, absorption, microbial quality, and changes during storage. An excipient accepted in one dosage form or route is not automatically suitable for every other use.
Most approved excipients are well tolerated at the amounts used, but reactions can occur in susceptible people. Possible problems include allergy, intolerance, irritation, altered absorption, or effects from ingredients such as sugars, sodium, alcohols, dyes, or preservatives. Infants, people with metabolic disorders, and patients receiving large or repeated doses can have additional risks. Medication labels and professional product information should be reviewed when a specific excipient is a concern.
No. The active ingredient produces the intended therapeutic effect, while an excipient supports the dosage form, manufacturing process, stability, or delivery. An excipient can still have biological or tolerability effects in some circumstances.
Not always. Generic and brand-name products contain the same active ingredient but can use different inactive ingredients. These differences should not change the required clinical performance of an approved generic product.
Yes. Allergic reactions to excipients are uncommon but can occur with ingredients such as certain dyes, gelatin, polyethylene glycols, or preservatives. The suspected ingredient should be reviewed with a clinician or pharmacist.
They are called inactive because they are not intended to provide the medicine's primary therapeutic action. The term does not mean that they can never affect absorption, stability, or a patient's response.
General Anesthesia for Surgeons. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK493199/. Date Accessed August 6, 2026.
Propofol. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK430884/. Date Accessed August 6, 2026.
Etomidate. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK535364/. Date Accessed August 6, 2026.
Ketamine Hydrochloride Injection: Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f8b01c77-620d-4734-a771-b8524b65bcca. Date Accessed August 6, 2026.
Sevoflurane, USP Volatile Liquid for Inhalation: Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=22700993-851a-48aa-941e-1d2b6b04081f. Date Accessed August 6, 2026.